Hile Bio to cancel 2.24m restricted shares

Shanghai Hile Bio-Technology (SSE:603718) announced that it will repurchase and cancel 2,237,800 restricted shares initially granted under its 2023 restricted stock and stock option incentive plan. The decision, approved by the board on January 22, 2025, stems from the departure of 10 employees, the spin-off of subsidiaries affecting 16 employees, and one supervisory board member no longer being eligible. These personnel no longer meet the criteria for participation in the incentive plan, resulting in 1,750,000 shares being cancelled.